Epidemiological Characteristics, Antifungal Susceptibility, Risk Factors, and Outcomes of Candida Bloodstream Infection: A Ten-Year Surveillance in a Teaching Hospital in China

References

• Posteraro B, De Carolis E, Criscuolo M., et al. Candidaemia in haematological malignancy patients from a SEIFEM study: epidemiological patterns according to antifungal prophylaxis. Mycoses. 2020;63:900–910. doi:10.1111/myc.13130
   PubMed Web of Science ®Google Scholar
• Barac A, Cevik M, Colovic N, et al. Investigation of a healthcare-associated Candida tropicalis candidiasis cluster in a haematology unit and a systematic review of nosocomial outbreaks. Mycoses. 2020;63:326–333. doi:10.1111/myc.13048
   PubMed Web of Science ®Google Scholar
• Lourdes R, Beatriz B, Luz H, et al. A multi-centric Study of Candida bloodstream infection in Lima-Callao, Peru: species distribution, antifungal resistance and clinical outcomes. PLoS One. 2017;12(4):e0175172.
   PubMed Web of Science ®Google Scholar
• Schroeder M, Weber T, Denker T, et al. Epidemiology, clinical characteristics, and outcome of candidemia in critically ill patients in Germany: a single-center retrospective 10-year analysis. Ann Intensive Care. 2020;10:142. doi:10.1186/s13613-020-00755-8
   PubMed Web of Science ®Google Scholar
• Zheng YJ, Xie T, Wu L, et al. Epidemiology, species distribution, and outcome of nosocomial Candida spp. bloodstream infection in Shanghai: an 11-year retrospective analysis in a tertiary care hospital. Ann Clin Microbiol Antimicrob. 2021;20:34. doi:10.1186/s12941-021-00441-y
   PubMed Web of Science ®Google Scholar
• Xiao M, Chen SC, Kong F, et al. Distribution and antifungal susceptibility of Candida species causing candidemia in China: an Update from the CHIF-NET study. J Infect Dis. 2020;221:S139–S147. doi:10.1093/infdis/jiz573
   PubMed Web of Science ®Google Scholar
• Zakhem AE, Istambouli R, Alkozah M, et al. Predominance of Candida glabrata among non-albicans Candida species in a 16-year study of candidemia at a tertiary care center in Lebanon. Pathogens. 2021;10:82. doi:10.3390/pathogens10010082
   PubMed Web of Science ®Google Scholar
• Al-Dorzi HM, Sakkijha H, Khan R, et al. Invasive candidiasis in critically ill patients: a prospective cohort study in two tertiary care centers. Intensive Care Med. 2022;35(6):542–553. doi:10.1177/0885066618767835
   Web of Science ®Google Scholar
• Tariq SA, Wala AA, Norah AA, et al. A seven-year surveillance of Candida bloodstream infection at a university hospital in KSA. J Taibah Univ Med Sci. 2021;16(2):184–190.
   PubMed Web of Science ®Google Scholar
• Kato H, Yoshimura Y, Suido Y, et al. Mortality and risk factor analysis for Candida blood stream infection: a multicenter study. J Infect Chemother. 2019;25(5):341–345. doi:10.1016/j.jiac.2019.01.002
   PubMed Web of Science ®Google Scholar
• Santolaya ME, Thompson L, Benadof D, et al. A prospective, multi-center study of Candida bloodstream infections in Chile. PLoS One. 2019;14(3):e0212924. doi:10.1371/journal.pone.0212924
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute. Performance Standards for Antifungal Susceptibility Testing of Yeasts, M60. 2nd ed. Clinical and Laboratory Standards Institute; 2020.
   Google Scholar
• Arendrup MC, Friberg N, Mares M, et al. How to interpret MICs of antifungal compounds according to the revised clinical breakpoints v. 10.0 European committee on antimicrobial susceptibility testing (EUCAST). Clin Microbiol Infect. 2020;26:1464–1472. doi:10.1016/j.cmi.2020.06.007
   PubMed Web of Science ®Google Scholar
• Enoch DA, Yang H, Aliyu SH, et al. The Changing epidemiology of invasive fungal infections. Methods Mol Biol. 2017;1508:17–65.
   PubMedGoogle Scholar
• Koehler P, Stecher M, Cornely OA, et al. Morbidity and mortality of candidaemia in Europe: an epidemiologic meta-analysis. Clin Microbiol Infect. 2019;25(10):1200–1212. doi:10.1016/j.cmi.2019.04.024
   PubMed Web of Science ®Google Scholar
• Xiao M, Sun ZY, Kang M, et al. Five-year national surveillance of invasive candidiasis: species distribution and azole susceptibility from the China Hospital Invasive Fungal Surveillance Net (CHIF-NET) study. J Clin Microbiol. 2018;56(7):e00577–18. doi:10.1128/JCM.00577-18
   PubMed Web of Science ®Google Scholar
• Eschenauer GA, Carver PL, Patel TS, et al. Survival in patients with Candida glabrata bloodstream infection is associated with fluconazole dose. Antimicrob Agents Chemother. 2018;62(6):e02566–17. doi:10.1128/AAC.02566-17
   PubMed Web of Science ®Google Scholar
• Arias S, Denis O, Montesinos I, et al. Epidemiology and mortality of candidemia both related and unrelated to the central venous catheter: a retrospective cohort study. Eur J Clin Microbiol Infect Dis. 2017;36(3):501–507. doi:10.1007/s10096-016-2825-3
   PubMed Web of Science ®Google Scholar
• Zhang L, Yu SY, Ning YT, et al. Multicenter retrospective study on antifungals susceptibility and molecular epidemiology of Candida parapsilosis isolated from bloodstream infections in China. Chin J Mycol. 2021;16(5):289–295.
   Google Scholar
• Chen YZ, Xia Y. Laboratory characteristics of candidemia in terms of immune status of patients. Chin J Infect Chemother. 2020;20(1):465–469.
   Google Scholar
• Vaquero-Herrero MP, Ragozzino S, Iriart X, et al. Candida bloodstream infection in patients with systemic autoimmune diseases. Med Mal Infect. 2020;50(4):372–376. doi:10.1016/j.medmal.2020.01.014
   PubMed Web of Science ®Google Scholar
• Chen X, Yang YW, Li YM, et al. Clinical characteristics and risk factors for death in patients with Candida bloodstream infection in Intensive Care Unit. J Cent South Univ. 2021;46(7):719–724.
   Google Scholar
• Cao HW, Zhao XH, Lu SY, et al. Relationship between development of an infection after chemotherapy and immune function and intestinal microecology in patients with a hematologic malignancy. Pathog Biol. 2017;12(5):456–459.
   Google Scholar
• Bongomin F, Gago S, Oladele RO, Denning DW. Global and multi-national prevalence of fungal diseases-estimate precision. J Fungi. 2017;3:57. doi:10.3390/jof3040057
   Web of Science ®Google Scholar
• Gunsalus KT, Tornberg-Belanger SN, Matthan NR, Lichtenstein AH, Kumamoto CA. Manipulation of host diet to reduce gastrointestinal colonization by the opportunistic pathogen Candida albicans. MSphere. 2015;1(1):e00020–15. doi:10.1128/mSphere.00020-15
   PubMed Web of Science ®Google Scholar
• Huang TT, Xia WY, Xu YQ, et al. A salt controlled scalable approach for formation of polyelectrolyte complex fiber†. Chin J Infect Chemother. 2020;20(5):465–469. doi:10.1002/cjoc.201900496
   Google Scholar
• Ye NF, Liu Z, Tang W, et al. Systematic characterization of epidemiology, antifungal susceptibility, risk factors and outcomes of candidaemia: a six-year Chinese study. Infect Drug Resist. 2022;15:4887–4898. doi:10.2147/IDR.S378629
   PubMed Web of Science ®Google Scholar
• Chaiyapong N, Piriyaporn C, Amiroh W, et al. Risk factors and outcomes of non-albicans Candida bloodstream infection in patients with candidemia at siriraj hospital-Thailand’s largest national tertiary referral hospital. J Fungi. 2021;7(4):269.
   Web of Science ®Google Scholar
• Jin F, Xia WY, Ni F, et al. Epidemiology, risk factors, and prognosis of Candida albicans and non-albicans candidemia. J Nanjing Med Univ. 2022;42(3):401–405.
   Google Scholar
• Jing R, Hou X, Xiao M, et al. A retrospective analysis of invasive yeast strains in China Hospital Invasive Fungal Surveillance Net from 2010 to 2014: changing pattern of species distribution and azoles susceptibility. Chin J Infect Chemother. 2020;20(2):175–180.
   Google Scholar
• Liu WJ, Sun HL, Zhang XJ. Analysis the pathogen distribution and Drug susceptibility of yeast bloodstream infection in Peking Union Medical College Hospital from 2014 to 2018. Chin J Mycol. 2019;14(6):357–361.
   Google Scholar